Resolve Stroke Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $2.37M

  • Investors
  • 9

Resolve Stroke General Information

Description

Developer of a healthcare technology designed to expand medical imaging and open a new area for neuro biomarkers. The company's technology widens applications for macro and microvascular imaging by improving contrast, resolution, and penetration depth of ultrasound, and is also used to improve conventional ultrasound imaging that is injected into the blood flow, enabling healthcare professionals to have images of micro-vessels through the human skull and in 3D in vitro.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Paris Santé Cochin
  • 29 rue du Faubourg Saint-Jacques
  • 75014 Paris
  • France
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Paris Santé Cochin
  • 29 rue du Faubourg Saint-Jacques
  • 75014 Paris
  • France

Resolve Stroke Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Resolve Stroke Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 18-Sep-2023 $2.37M Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2023 Completed Startup
3. Accelerator/Incubator 31-May-2022 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view Resolve Stroke’s complete valuation and funding history, request access »

Resolve Stroke Patents

Resolve Stroke Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026082976-A1 Method and system for perfusion imaging Pending 18-Oct-2024
FR-3167538-A1 Perfusion imaging method and system Pending 18-Oct-2024
FR-3142262-A1 Method and system for ultrasonic acquisition and processing Active 17-Nov-2022
EP-4619779-A1 Method and system for ultrasound acquisition and processing Pending 17-Nov-2022
FR-3142262-B1 Method and system for ultrasound acquisition and processing Active 17-Nov-2022 G01S15/8995
To view Resolve Stroke’s complete patent history, request access »

Resolve Stroke Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Resolve Stroke Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Audacia Growth/Expansion Minority
Bpifrance Sovereign Wealth Fund Minority
Kima Ventures Venture Capital Minority
OVNI Capital Venture Capital Minority
Quantonation Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Resolve Stroke FAQs

  • When was Resolve Stroke founded?

    Resolve Stroke was founded in 2022.

  • Where is Resolve Stroke headquartered?

    Resolve Stroke is headquartered in Paris, France.

  • What is the size of Resolve Stroke?

    Resolve Stroke has 20 total employees.

  • What industry is Resolve Stroke in?

    Resolve Stroke’s primary industry is Other Devices and Supplies.

  • Is Resolve Stroke a private or public company?

    Resolve Stroke is a Private company.

  • What is the current valuation of Resolve Stroke?

    The current valuation of Resolve Stroke is .

  • What is Resolve Stroke’s current revenue?

    The current revenue for Resolve Stroke is .

  • How much funding has Resolve Stroke raised over time?

    Resolve Stroke has raised $2.37M.

  • Who are Resolve Stroke’s investors?

    Audacia, Bpifrance, Kima Ventures, OVNI Capital, and Quantonation are 5 of 9 investors who have invested in Resolve Stroke.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process